Skip to content
Search

Latest Stories

Study reveals how Covid-19 pandemic impacted pharmacists' mental health

Nearly a third of community pharmacists say Covid-19 has adversely impacted their mental health and wellbeing to a significant extent.

A joint study run by the Royal Pharmaceutical Society (RPS) and the Pharmacist Support charity has revealed that over half (54 per cent) of pharmacists believed the pandemic had impacted their mental health to some extent.


The survey revealed that 40 per cent of the respondents felt their mental health was ‘okay’ during the pandemic but 33 per cent said it was not good and a further 10 per cent said it was poor.

Around 72 per cent of respondents said the virus had negatively affected their mental health and wellbeing at their workplace.

Increased demand, inadequate staffing, long working hours, and a lack of breaks and time off have adversely impacted the pharmacy team members at their respective workplaces.

“This figure is comparable with the 2019 survey (74 per cent), showing that whilst Covid-19 may have exacerbated these issues, they pre-existed the pandemic,” the RPS said.

Mental health at workplace

Around 57 per cent of employers provided mental health and wellbeing support, whereas 44 per cent of pharmacists reported feeling uncomfortable about accessing it.

“Reasons given for this centred on confidentiality and trust, particularly stigma, judgement and the potential for it to harm their career. Of this group, those working in community (51 per cent) were most reluctant to access support, compared to colleagues in general practice (46 per cent) and hospital (31 per cent),” the survey showed.

A vast majority (89 per cent) reported as being at high risk of burnout – an increase from 80 per cent in from the 2019 survey. One-third (33 per cent) of respondents had considered leaving their job, while a further third (34 per cent) had considered leaving the profession.

The survey received a total of 959 responses. Over half of the respondents worked in community practice, and a fifth worked in hospital, with representation from England (76 per cent), Scotland (15 per cent) and Wales (eight per cent).

RPS president Sandra Gidley said: “We’ve all felt the consequences of extra pressures brought by the pandemic. It’s been incredibly tough and caused enormous stress and increased workloads for pharmacy teams. We need to ensure support is available for those who need it, whilst preventing problems from happening by tackling some of the root causes of poor mental health and wellbeing in the workplace.

“Flexible opening hours have been enormously helpful in managing workloads and should become a permanent adaptation, rather than a short-term measure. Having the right staffing levels and skill mix in the pharmacy to support safe and effective patient care should be a given. And being able to take breaks, to relieve the pressure or for CPD to learn something new, is essential.

“Our campaigning led to access to NHS wellbeing services being granted to pharmacists and their teams for the first time. We want to see this continue beyond the pandemic and extended to include access to NHS occupational health services too. It would be deeply unjust if support for the country’s third largest health profession, who have worked so hard this year, was simply switched off once the immediate crisis is over”.

Chief executive of Pharmacist Support Danielle Hunt said: “A clear concern for us from these results is that there are a number of barriers to accessing mental health and wellbeing support for pharmacists and pharmacy students.

“Although the reasons behind this may not always be clear, a large percentage point to a lack of awareness and concerns around confidentiality and stigma. Worryingly there is also a gap in awareness amongst BAME respondents of employer or NHS-funded occupational services…”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less